Laboratory study demonstrates biofilm eradication and cancer cell inhibition by phyto-fabricated silver nanoparticles, indicating versatile biomedical and environmental applications.
The development of sustainable nanomaterials through plant-mediated synthesis has gained considerable attention as an alternative to conventional chemical approaches. In the present study, silver nanoparticles (AgNPs) were synthesized for the first time using a hydroalcoholic leaf extract of Talinum paniculatum and comprehensively evaluated for their biomedical and environmental applications. Formation of AgNPs was confirmed by a characteristic surface plasmon resonance peak at 422 nm. The biosynthesized nanoparticles were predominantly spherical with particle sizes ranging from 5 to 35 nm and an average diameter of approximately 22 nm, while XRD analysis revealed a highly crystalline face-centered cubic structure with a crystallite size of 20 nm. Dynamic light scattering showed a hydrodynamic size of 70 nm and a zeta potential of −33.1 mV, indicating good colloidal stability. The AgNPs exhibited broad-spectrum antibacterial activity and significantly suppressed Pseudomonas aeruginosa biofilm formation, achieving approximately 90.45 ± 3.56% inhibition at 200 μg/mL. Molecular docking against the quorum-sensing regulator LasR demonstrated stable binding within the ligand-binding pocket with a binding affinity of −5.02 kcal/mol, suggesting interference with quorum-sensing-mediated virulence. The nanoparticles displayed strong antioxidant activity, with 96.66 ± 3.14% DPPH radical scavenging and an IC₅₀ of 120 μg/mL. Hemocompatibility studies showed less than 10% hemolysis at 15.25 μg/mL. Furthermore, AgNPs induced marked cytotoxicity against MCF-7 breast cancer cells, producing 75.8 ± 2.56% growth inhibition at 250 μg/mL. Photocatalytic studies revealed 96.19% degradation of methylene blue within 70 min of sunlight irradiation. These findings establish T. paniculatum -derived AgNPs as multifunctional nanomaterials with promising prospects for antimicrobial, anticancer, and environmental remediation applications.
No takes yet. Share an insight, caveat, or question.
Dhanabalan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: